The PRADO COPD improves quality of care but without decreasing rehospitalizations and mortality, although rehospitalizations did decrease among PRADO group patients benefiting from an optimal care pathway.
Keyphrases
- quality improvement
- chronic obstructive pulmonary disease
- healthcare
- end stage renal disease
- palliative care
- newly diagnosed
- chronic kidney disease
- ejection fraction
- prognostic factors
- peritoneal dialysis
- pain management
- cardiovascular events
- type diabetes
- lung function
- cardiovascular disease
- affordable care act
- patient reported outcomes
- cystic fibrosis
- chronic pain
- air pollution